Navigation Links
Georgia Power to Delay Plant Mitchell Conversion to Biomass
Date:1/8/2010

ATLANTA, Jan. 8 /PRNewswire-FirstCall/ -- With the uncertainty of how future U.S. Environmental Protection Agency (EPA) regulations might affect industrial boiler emissions, Georgia Power has decided to delay the conversion of coal-fueled Plant Mitchell in Albany, Ga., to biomass until the EPA rules are better defined in April 2010.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050216/CLW066LOGO )

The anticipated industrial boiler Maximum Achievable Control Technology rule, or "IB MACT," would regulate emissions of hazardous air pollutants, such as certain acid gases, organics, metals, and possibly other pollutants, from industrial boilers and would likely affect biomass boilers like the one planned for Plant Mitchell.

"Georgia Power is committed to furthering the development of renewable energy in Georgia," said Jeff Burleson, Georgia Power's director of Resource Policy and Planning. "We're disappointed to have to delay this large biomass project and the benefits it can deliver. However, by delaying capital spending on the project we're significantly reducing the cost risk to customers."

Georgia Power had originally planned to begin retrofit construction at Plant Mitchell in April 2011 with the unit becoming operational in June 2012. A new project schedule has yet to be determined.

Once the new EPA rules are better defined, Georgia Power will evaluate the potential impact they might have on the conversion project at Plant Mitchell. The company plans to study other boiler technologies in the event the rules significantly impact the cost of the biomass boiler conversion currently planned for the plant.

Upon conversion, Plant Mitchell will have lower emissions and will be one of the largest wood biomass plants in the United States. It will also have lower fuel and operating costs when compared to continued operation using coal, thereby making the plant more cost-effective for customers.

Georgia Power is the largest subsidiary of Southern Company, one of the nation's largest generators of electricity. The company is an investor-owned, tax-paying utility with rates well below the national average. Georgia Power serves 2.3 million customers in all but four of Georgia's 159 counties.

www.georgiapower.com

SOURCE Georgia Power

RELATED LINKS
http://www.georgiapower.com

'/>"/>

SOURCE Georgia Power
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Arts Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia
2. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
3. Big Win for Huge Coral Reefs off NC, SC, Georgia, Florida
4. Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia
5. Natural Fuels Industries Eyes Biomass Rich Georgia for Production Facility
6. The Biotechnology Industry Organization Honors Georgia Governor Sonny Perdue as Governor of the Year
7. Researchers at the University of Georgia Discover Protein is Crucial to Reproduction of Parasites Involved in Disease
8. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
9. Ceres Trials Energy Crops at Georgia Biofuel Facility
10. Governor Perdue Announces Georgia Selected as Home for New National Health Museum
11. Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 ... $7M Series B financing, adding an additional $3M from ... by Mesa Verde Venture Partners and other strategic partners ... directed towards further accelerating commercial adoption of their flagship ... test and expanding the Paradigm cancer registry. ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, will host ... at 8:00 AM EST on Thursday, February 16, 2017 ... program, the recently announced closing of a $10.5 million ... To participate in the live call and take ...
Breaking Biology Technology:
(Date:2/6/2017)... DENVER , Feb. 6, 2017 ... national security are driving border authorities to continue ... Acuity reports there are 2143 Automated Border Control ... Kiosks currently deployed at more than 163 ports ... between 2013 to 2016 achieving a combined CAGR ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/1/2017)... Massachusetts , February 1, 2017 IDTechEx ... events on emerging technology, announces the availability of a new report, ... Continue Reading ... ... in industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: ...
Breaking Biology News(10 mins):